Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 271028, 13 pages
http://dx.doi.org/10.1155/2012/271028
Review Article

The Metabolic Syndrome, Oxidative Stress, Environment, and Cardiovascular Disease: The Great Exploration

Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, 307 North University Boulevard, Mobile, AL 36688, USA

Received 6 April 2012; Accepted 21 May 2012

Academic Editor: Asli F. Ceylan-Isik

Copyright © 2012 Rebecca Hutcheson and Petra Rocic. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Grundy, “Metabolic syndrome pandemic,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 4, pp. 629–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. W. F. Wilson, W. B. Kannel, H. Silbershatz, and R. B. D'Agostino, “Clustering of metabolic factors and coronary heart disease,” Archives of Internal Medicine, vol. 159, no. 10, pp. 1104–1109, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Suzuki, K. Hirata, M. S. V. Elkind et al., “Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan study (NOMAS),” American Heart Journal, vol. 156, no. 2, pp. 405–410, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. E. S. Ford, W. H. Giles, and A. H. Mokdad, “Increasing prevalence of the metabolic syndrome among U.S. adults,” Diabetes Care, vol. 27, no. 10, pp. 2444–2449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Sookoian and C. J. Pirola, “Genetics of the cardiometabolic syndrome: new insights and therapeutic implications,” Therapeutic Advances in Cardiovascular Disease, vol. 1, no. 1, pp. 37–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation,” Diabetic Medicine, vol. 23, no. 5, pp. 469–480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Ärnlöv, E. Ingelsson, J. Sundström, and L. Lind, “Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men,” Circulation, vol. 121, no. 2, pp. 230–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Noda, H. Iso, I. Saito, M. Konishi, M. Inoue, and S. Tsugane, “The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study,” Hypertension Research, vol. 32, no. 4, pp. 289–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Lassègue and K. K. Griendling, “NADPH oxidases: functions and pathologies in the vasculature,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 4, pp. 653–661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Cavalca, F. Veglia, I. Squellerio et al., “Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender,” European Journal of Clinical Investigation, vol. 39, no. 4, pp. 267–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Azumi, N. Inoue, Y. Ohashi et al., “Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 11, pp. 1838–1844, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Folli, D. Corradi, P. Fanti et al., “The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro-and macrovascular complications: avenues for a mechanistic-based therapeutic approach,” Current Diabetes Reviews, vol. 7, no. 5, pp. 313–324, 2011. View at Google Scholar · View at Scopus
  13. A. Fortuño, G. San José, M. U. Moreno, O. Beloqui, J. Díez, and G. Zalba, “Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome,” Diabetes, vol. 55, no. 1, pp. 209–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Hansel, P. Giral, E. Nobecourt et al., “Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 10, pp. 4963–4971, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. C. K. Roberts, R. J. Barnard, R. K. Sindhu, M. Jurczak, A. Ehdaie, and N. D. Vaziri, “Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome,” Metabolism, vol. 55, no. 7, pp. 928–934, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. E. S. Ford, A. H. Mokdad, W. H. Giles, and D. W. Brown, “The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey,” Diabetes, vol. 52, no. 9, pp. 2346–2352, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Perticone, R. Ceravolo, M. Candigliota et al., “Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C,” Diabetes, vol. 50, no. 1, pp. 159–165, 2001. View at Google Scholar · View at Scopus
  18. D. Montero, G. Walther, A. Perez-Martin, E. Roche, and A. Vinet, “Endothelial dysfunction, inflammation, and oxidative stress in obese children and adolescents: markers and effect of lifestyle intervention,” Obesity Reviews, vol. 13, no. 5, pp. 441–455, 2012. View at Google Scholar
  19. R. S. Rector, S. O. Warner, Y. Liu et al., “Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome,” American Journal of Physiology, vol. 293, no. 2, pp. E500–E506, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. K. Roberts, D. Won, S. Pruthi et al., “Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors,” Journal of Applied Physiology, vol. 100, no. 5, pp. 1657–1665, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Furukawa, T. Fujita, M. Shimabukuro et al., “Increased oxidative stress in obesity and its impact on metabolic syndrome,” Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752–1761, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Houstis, E. D. Rosen, and E. S. Lander, “Reactive oxygen species have a causal role in multiple forms of insulin resistance,” Nature, vol. 440, no. 7086, pp. 944–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. de Mattia, M. C. Bravi, O. Laurenti et al., “Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications,” Diabetes Research and Clinical Practice, vol. 79, no. 2, pp. 337–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. de Oliveira, M. A. Hort, E. L. G. Moreira et al., “Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress,” Neuroscience, vol. 197, pp. 99–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Marques de Mattos, L. V. Marino, P. P. Ovidio, A. A. Jordão, C. C. Almeida, and P. G. Chiarello, “Protein oxidative stress and dyslipidemia in dialysis patients,” Therapeutic Apheresis and Dialysis, vol. 16, no. 1, pp. 68–74, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Zelzer, N. Fuchs, G. Almer et al., “High density lipoprotein cholesterol level is a robust predictor of lipid peroxidation irrespective of gender, age, obesity, and inflammatory or metabolic biomarkers,” Clinica Chimica Acta, vol. 412, no. 15-16, pp. 1345–1349, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Andreadou, D. Farmakis, E. Prokovas et al., “Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress,” Cardiovascular Research, vol. 94, no. 3, pp. 501–509, 2012. View at Google Scholar
  28. J. A. Ansari, U. Bhandari, K. K. Pillai, and S. E. Haque, “Effect of rosuvastatin on obesity-induced cardiac oxidative stress in wistar rats—a preliminary study,” Indian Journal of Experimental Biology, vol. 50, no. 3, pp. 216–222, 2012. View at Google Scholar · View at Scopus
  29. N. C. Ward, J. M. Hodgson, I. B. Puddey, T. A. Mori, L. J. Beilin, and K. D. Croft, “Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle,” Free Radical Biology and Medicine, vol. 36, no. 2, pp. 226–232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Redón, M. R. Oliva, C. Tormos et al., “Antioxidant activities and oxidative stress byproducts in human hypertension,” Hypertension, vol. 41, no. 5, pp. 1096–1101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Wang, S. Strandgaard, J. Iversen, and C. S. Wilcox, “Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension,” American Journal of Physiology, vol. 296, no. 2, pp. R195–R200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Abdilla, M. C. Tormo, M. J. Fabia, F. J. Chaves, G. Saez, and J. Redon, “Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension,” Journal of Human Hypertension, vol. 21, no. 1, pp. 68–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. H. J. Chen and W. H. Pan, “Probable blind spot in the international diabetes federation definition of metabolic syndrome,” Obesity, vol. 15, no. 5, pp. 1096–1100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Monami, N. Marchionni, G. Masotti, and E. Mannucci, “IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients,” Diabetes, Obesity and Metabolism, vol. 9, no. 3, pp. 350–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Sanchez, P. Fischer, L. Cuniberti, L. D. Masnatta, and A. J. Ramírez, “Vascular oxidative stress is associated with insulin resistance in hyper-reninemic nonmodulating essential hypertension,” Journal of Hypertension, vol. 25, no. 12, pp. 2434–2440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Cottone, G. Mulè, E. Nardi et al., “C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension,” Journal of Hypertension, vol. 25, no. 2, pp. 423–428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. Somers, K. Mavromatis, Z. S. Galis, and D. G. Harrison, “Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt,” Circulation, vol. 101, no. 14, pp. 1722–1728, 2000. View at Google Scholar · View at Scopus
  38. U. Landmesser, H. Cai, S. Dikalov et al., “Role of p47phox in vascular oxidative stress and hypertension caused by angiotensin II,” Hypertension, vol. 40, no. 4, pp. 511–515, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Heitzer, U. Wenzel, U. Hink et al., “Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C,” Kidney International, vol. 55, no. 1, pp. 252–260, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Rajagopalan, S. Kurz, T. Münzel et al., “Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone,” Journal of Clinical Investigation, vol. 97, no. 8, pp. 1916–1923, 1996. View at Google Scholar · View at Scopus
  41. D. S. Freedman, W. H. Dietz, S. R. Srinivasan, and G. S. Berenson, “The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart study,” Pediatrics, vol. 103, no. 6 I, pp. 1175–1182, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. G. S. Berenson, S. R. Srinivasan, W. Bao, W. P. Newman, R. E. Tracy, and W. A. Wattigney, “Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults,” The New England Journal of Medicine, vol. 338, no. 23, pp. 1650–1656, 1998. View at Publisher · View at Google Scholar · View at Scopus
  43. O. Galili, D. Versari, K. J. Sattler et al., “Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress,” American Journal of Physiology, vol. 292, no. 2, pp. H904–H911, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. S. Kelly, J. Steinberger, D. R. Kaiser, T. P. Olson, A. J. Bank, and D. R. Dengel, “Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children,” Journal of the Cardiometabolic syndrome, vol. 1, no. 4, pp. 248–252, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. J. Ghio, M. S. Carraway, and M. C. Madden, “Composition of air pollution particles and oxidative stress in cells, tissues, and living systems,” Journal of Toxicology and Environmental Health Part B, vol. 15, no. 1, pp. 1–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. K. J. Chuang, C. C. Chan, T. C. Su, C. T. Lee, and C. S. Tang, “The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 4, pp. 370–376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. N. L. Mills, K. Donaldson, P. W. Hadoke et al., “Adverse cardiovascular effects of air pollution,” Nature Clinical Practice Cardiovascular Medicine, vol. 6, no. 1, pp. 36–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Zanobetti, M. Franklin, P. Koutrakis, and J. Schwartz, “Fine particulate air pollution and its components in association with cause-specific emergency admissions,” Environmental Health, vol. 8, no. 1, article 58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Tonstad and M. Svendsen, “Premature coronary heart disease, cigarette smoking, and the metabolic syndrome,” The American Journal of Cardiology, vol. 96, no. 12, pp. 1681–1685, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. C. C. Chen, T. C. Li, P. C. Chang et al., “Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan,” Metabolism, vol. 57, no. 4, pp. 544–548, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Nakatani, Y. Sakata, H. Sato et al., “Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction,” The American Journal of Cardiology, vol. 99, no. 7, pp. 885–889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Zhang, S. Jiang, and R. R. Watson, “Antioxidant supplementation prevents oxidation and inflammatory responses induced by sidestream cigarette smoke in old mice,” Environmental Health Perspectives, vol. 109, no. 10, pp. 1007–1009, 2001. View at Google Scholar · View at Scopus
  53. H. Chen, M. S. Goldberg, and P. J. Viileneuve, “A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases,” Reviews on Environmental Health, vol. 23, no. 4, pp. 243–297, 2008. View at Google Scholar · View at Scopus
  54. J. B. Henrotin, M. Zeller, L. Lorgis, Y. Cottin, M. Giroud, and Y. Béjot, “Evidence of the role of short-term exposure to ozone on ischaemic cerebral and cardiac events: the Dijon Vascular project (DIVA),” Heart, vol. 96, no. 24, pp. 1990–1996, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Mustafić, P. Jabre, C. Caussin et al., “Main air pollutants and myocardial infarction: a systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 307, no. 7, pp. 713–721, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. R. D. Brook, S. Rajagopalan, C. A. Pope et al., “Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the american heart association,” Circulation, vol. 121, no. 21, pp. 2331–2378, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. M. A. Pereira Filho, L. A. A. Pereira, F. F. Arbex et al., “Effect of air pollution on diabetes and cardiovascular diseases in São Paulo, Brazil,” Brazilian Journal of Medical and Biological Research, vol. 41, no. 6, pp. 526–532, 2008. View at Google Scholar · View at Scopus
  58. T. F. Bateson and J. Schwartz, “Who is sensitive to the effects of particulate air pollution on mortality? A case-crossover analysis of effect modifiers,” Epidemiology, vol. 15, no. 2, pp. 143–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. S. K. Park, A. H. Auchincloss, M. S. O'Neill et al., “Particulate air pollution, metabolic syndrome, and heart rate variability: the multi-ethnic study of atherosclerosis (MESA),” Environmental Health Perspectives, vol. 118, no. 10, pp. 1406–1411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. H. P. Cotrim, F. Carvalho, A. C. Siqueira, M. Lordelo, R. Rocha, and L. A. R. de Freitas, “Nonalcoholic fatty liver and insulin resistance among petrochemical workers,” The Journal of the American Medical Association, vol. 294, no. 13, pp. 1618–1620, 2005. View at Google Scholar · View at Scopus
  61. Y. Sirit, C. Acero, M. Bellorin, and R. Portillo, “Metabolic syndrome and other factors cardiovascular risk in workers of a plant of vinyl polychloride,” Revista de Salud Publica, vol. 10, no. 2, pp. 239–249, 2008. View at Google Scholar · View at Scopus
  62. V. Mohan, M. Deepa, S. Farooq, D. Prabhakaran, and K. S. Reddy, “Surveillance for risk factors of cardiovascular disease among an industrial population in Southern India,” National Medical Journal of India, vol. 21, no. 1, pp. 8–13, 2008. View at Google Scholar · View at Scopus
  63. I. A. Lang, T. S. Galloway, A. Scarlett et al., “Association of Urinary Bisphenol A concentration with medical disorders and laboratory abnormalities in adults,” The Journal of the American Medical Association, vol. 300, no. 11, pp. 1303–1310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. K. Sakurai, M. Kawazuma, T. Adachi et al., “Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes,” British Journal of Pharmacology, vol. 141, no. 2, pp. 209–214, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. W. C. Prozialeck, J. R. Edwards, D. W. Nebert, J. M. Woods, A. Barchowsky, and W. D. Atchison, “The vascular system as a target of metal toxicity,” Toxicological Sciences, vol. 102, no. 2, pp. 207–218, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. S. L. Wang, J. M. Chiou, C. J. Chen et al., “Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in Southwestern arseniasis-endemic and nonendemic areas in Taiwan,” Environmental Health Perspectives, vol. 111, no. 2, pp. 155–159, 2003. View at Google Scholar · View at Scopus
  67. M. Rahman, M. Tondel, S. A. Ahmad, and O. Axelson, “Diabetes mellitus associated with arsenic exposure in Bangladesh,” American Journal of Epidemiology, vol. 148, no. 2, pp. 198–203, 1998. View at Google Scholar · View at Scopus
  68. H. I. Afridi, T. G. Kazi, N. Kazi et al., “Evaluation of status of toxic metals in biological samples of diabetes mellitus patients,” Diabetes Research and Clinical Practice, vol. 80, no. 2, pp. 280–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Navas-Acien, E. K. Silbergeld, R. Pastor-Barriuso, and E. Guallar, “Arsenic exposure and prevalence of type 2 diabetes in US adults,” The Journal of the American Medical Association, vol. 300, no. 7, pp. 814–822, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. D. S. Paul, A. W. Harmon, V. Devesa, D. J. Thomas, and M. Stýblo, “Molecular mechanisms of the diabetogenic effects of arsenic inhibition of insulin signaling by arsenite and methylarsonous acid,” Environmental Health Perspectives, vol. 115, no. 5, pp. 734–742, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. Q. Sun, P. Yue, J. A. Deiuliis et al., “Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity,” Circulation, vol. 119, no. 4, pp. 538–546, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. K. Esposito, R. Marfella, M. Ciotola et al., “Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial,” The Journal of the American Medical Association, vol. 292, no. 12, pp. 1440–1446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Cottone, G. Mulè, E. Nardi et al., “Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension,” American Journal of Hypertension, vol. 19, no. 3, pp. 313–318, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. J. L. Abramson, W. C. Hooper, D. P. Jones et al., “Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease,” Atherosclerosis, vol. 178, no. 1, pp. 115–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Fitó, M. Cladellas, R. de la Torre et al., “Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial,” Atherosclerosis, vol. 181, no. 1, pp. 149–158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. J. H. John, S. Ziebland, P. Yudkin, L. S. Roe, and H. A. W. Neil, “Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial,” The Lancet, vol. 359, no. 9322, pp. 1969–1974, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Basu, K. Sanchez, M. J. Leyva et al., “Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome,” Journal of the American College of Nutrition, vol. 29, no. 1, pp. 31–40, 2010. View at Google Scholar · View at Scopus
  78. R. A. Stancliffe, T. Thorpe, and M. B. Zemel, “Dairy attentuates oxidative and inflammatory stress in metabolic syndrome,” The American Journal of Clinical Nutrition, vol. 94, no. 2, pp. 422–430, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. F. Antonini-Canterin, S. la Carrubba, G. Gullace et al., “Association between carotid atherosclerosis and metabolic syndrome: results from the ISMIR study,” Angiology, vol. 61, no. 5, pp. 443–448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Kawamoto, H. Tomita, N. Ohtsuka, A. Inoue, and A. Kamitani, “Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness,” Journal of Atherosclerosis and Thrombosis, vol. 14, no. 2, pp. 78–85, 2007. View at Google Scholar · View at Scopus
  81. B. Iglseder, P. Cip, L. Malaimare, G. Ladurner, and B. Paulweber, “The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men,” Stroke, vol. 36, no. 6, pp. 1212–1217, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. K. E. Kip, O. C. Marroquin, D. E. Kelley et al., “Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the women's ischemia syndrome evaluation (WISE) study,” Circulation, vol. 109, no. 6, pp. 706–713, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. V. L. Roger, A. S. Go, D. M. Lloyd-Jones et al., “Heart disease and stroke statistics—2011 update: a report from the American Heart Association,” Circulation, vol. 123, pp. e18–e209, 2011. View at Google Scholar
  84. J. Y. Kim, H. S. Mun, B. K. Lee et al., “Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease,” Yonsei Medical Journal, vol. 51, no. 5, pp. 676–682, 2010. View at Publisher · View at Google Scholar · View at Scopus
  85. G. Schernthaner, “Cardiovascular mortality and morbidity in type-2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 31, pp. S3–S13, 1996. View at Publisher · View at Google Scholar · View at Scopus
  86. H. M. Lakka, D. E. Laaksonen, T. A. Lakka et al., “The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men,” The Journal of the American Medical Association, vol. 288, no. 21, pp. 2709–2716, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Kotur-Stevuljevic, L. Memon, A. Stefanovic et al., “Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients,” Clinical Biochemistry, vol. 40, no. 3-4, pp. 181–187, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. C. Meisinger, J. Baumert, N. Khuseyinova, H. Loewel, and W. Koenig, “Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population,” Circulation, vol. 112, no. 5, pp. 651–657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. K. Kajimoto, T. Kasai, K. Miyauchi et al., “Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery,” Circulation Journal, vol. 72, no. 9, pp. 1481–1486, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. M. L. Brackbill, C. S. Sytsma, and K. Sykes, “Perioperative outcomes of coronary artery bypass grafting: effects of metabolic syndrome and patient's sex,” American Journal of Critical Care, vol. 18, no. 5, pp. 468–473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. R. Hoffmann, E. Stellbrink, J. Schröder et al., “Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents,” The American Journal of Cardiology, vol. 100, no. 9, pp. 1347–1352, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. K. Yaginuma, T. Kasai, K. Miyauchi, K. Kajimoto, A. Amano, and H. Daida, “Propensity score analysis of 10-year long-term outcome after bypass surgery or plain old balloon angioplasty in patients with metabolic syndrome,” International Heart Journal, vol. 52, no. 6, pp. 372–376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. S. P. Marso, J. W. Murphy, J. A. House, D. M. Safley, and W. S. Harris, “Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention,” Diabetes and Vascular Disease Research, vol. 2, no. 1, pp. 31–36, 2005. View at Google Scholar · View at Scopus
  94. M. Almalla, J. Schröder, V. Deserno et al., “Long-term clinical outcome of sirolimus-eluting stent implantation in metabolic syndrome and diabetes,” Journal of Invasive Cardiology, vol. 22, no. 7, pp. 317–321, 2010. View at Google Scholar · View at Scopus
  95. R. Hu, C. S. Ma, S. P. Nie et al., “Effect of metabolic syndrome on prognosis and clinical characteristics of revascularization in patients with coronary artery disease,” Chinese Medical Journal, vol. 119, no. 22, pp. 1871–1876, 2006. View at Google Scholar · View at Scopus
  96. T. Onishi, K. Shimada, S. Sunayama et al., “Effects of cardiac rehabilitation in patients with metabolic syndrome after coronary artery bypass grafting,” Journal of Cardiology, vol. 53, no. 3, pp. 381–387, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. S. H. Sung, T. C. Wu, C. H. Huang, S. J. Lin, and J. W. Chen, “Prognostic impact of body mass index in patients undergoing coronary artery bypass surgery,” Heart, vol. 97, no. 8, pp. 648–654, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. J. A. M. Foody, F. D. Ferdinand, G. L. Pearce, B. W. Lytle, D. M. Cosgrove, and D. L. Sprecher, “HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from the Cleveland Clinic Foundation,” Circulation, vol. 102, no. 19, pp. III-90–III-94, 2000. View at Google Scholar · View at Scopus
  99. J. Yun, P. Rocic, Y. F. Pung et al., “Redox-dependent mechanisms in coronary collateral growth: the “redox window” hypothesis,” Antioxidants and Redox Signaling, vol. 11, no. 8, pp. 1961–1974, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. M. B. Yilmaz, V. Caldir, Y. Guray et al., “Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome,” The American Journal of Cardiology, vol. 97, no. 5, pp. 636–639, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. H. Sasmaz and M. B. Yilmaz, “Coronary collaterals in obese patients: impact of metabolic syndrome,” Angiology, vol. 60, no. 2, pp. 164–168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  102. F. Mouquet, F. Cuilleret, S. Susen et al., “Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1,” European Heart Journal, vol. 30, no. 7, pp. 840–849, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Reed, C. Kolz, B. Potter, and P. Rocic, “The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 1, pp. 61–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. N. Hattan, W. M. Chilian, F. Park, and P. Rocic, “Restoration of coronary collateral growth in the zucker obese rat: impact of VEGF and ecSOD,” Basic Research in Cardiology, vol. 102, no. 3, pp. 217–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. D. Weihrauch, N. L. Lohr, B. Mraovic et al., “Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin,” Circulation, vol. 109, no. 19, pp. 2343–2348, 2004. View at Publisher · View at Google Scholar · View at Scopus
  106. A. D. Lassaletta, L. M. Chu, M. P. Robich et al., “Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia,” Basic Research in Cardiology, vol. 107, no. 2, article 243, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. M. Mohri, H. Tomoike, M. Noma, T. Inoue, K. Hisano, and M. Nakamura, “Duration of ischemia is vital for collateral development: repeated brief coronary artery occlusion in conscious dogs,” Circulation Research, vol. 64, no. 2, pp. 287–296, 1989. View at Google Scholar · View at Scopus
  108. K. Yamanishi, M. Fujita, A. Ohno, and S. Sasayama, “Importance of myocardial ischemia for recruitment of coronary collateral circulation in dogs,” Cardiovascular Research, vol. 24, no. 4, pp. 271–277, 1990. View at Google Scholar · View at Scopus
  109. P. Rocic, C. Kolz, R. Reed, B. Potter, and W. M. Chilian, “Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth,” American Journal of Physiology, vol. 292, no. 6, pp. H2729–H2736, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. Y. F. Pung, P. Rocic, M. P. Murphy et al., “Resolution of mitochondrial oxidative stress rescues coronary collateral growth in zucker obese fatty rats,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 2, pp. 325–334, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. R. Reed, B. Potter, E. Smith et al., “Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome,” American Journal of Physiology, vol. 296, no. 6, pp. H1811–H1821, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. S. J. Miller, B. J. Coppinger, X. Zhou, and J. L. Unthank, “Antioxidants reverse age-related collateral growth impairment,” Journal of Vascular Research, vol. 47, no. 2, pp. 108–114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  113. E. Lonn, J. Bosch, S. Yusuf et al., “Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial,” The Journal of the American Medical Association, vol. 293, no. 11, pp. 1338–1347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  114. P. Knekt, J. Ritz, M. A. Pereira et al., “Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts,” The American Journal of Clinical Nutrition, vol. 80, no. 6, pp. 1508–1520, 2004. View at Google Scholar · View at Scopus
  115. B. Halliwell, “The antioxidant paradox,” The Lancet, vol. 355, no. 9210, pp. 1179–1180, 2000. View at Google Scholar · View at Scopus
  116. E. A. Meagher, O. P. Barry, J. A. Lawson, J. Rokach, and G. A. FitzGerald, “Effects of vitamin E on lipid peroxidation in healthy persons,” The Journal of the American Medical Association, vol. 285, no. 9, pp. 1178–1182, 2001. View at Google Scholar · View at Scopus
  117. S. Czernichow, A. C. Vergnaud, P. Galan et al., “Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults,” The American Journal of Clinical Nutrition, vol. 90, no. 2, pp. 329–335, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. N. Demircan, A. Gürel, F. Armutcu, M. Ünalacak, E. Aktunç, and H. Atmaca, “The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome,” Medical Science Monitor, vol. 14, no. 2, pp. CR97–CR101, 2008. View at Google Scholar · View at Scopus
  119. M. A. Beydoun, M. R. Shroff, X. Chen, H. A. Beydoun, Y. Wang, and A. B. Zonderman, “Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys,” Journal of Nutrition, vol. 141, no. 5, pp. 903–913, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. R. Cangemi, F. Angelico, L. Loffredo et al., “Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid,” Free Radical Biology and Medicine, vol. 43, no. 5, pp. 853–859, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. A. Basu, N. M. Betts, J. Ortiz, B. Simmons, M. Wu, and T. J. Lyons, “Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome,” Nutrition Research, vol. 31, no. 3, pp. 190–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  122. J. M. Upston, A. C. Terentis, K. Morris, J. F. Keaney Jr., and R. Stocker, “Oxidized lipid accumulates in the presence of α-tocopherol in atherosclerosis,” Biochemical Journal, vol. 363, no. 3, pp. 753–760, 2002. View at Publisher · View at Google Scholar · View at Scopus
  123. Seon Hwa Lee, T. Oe, and I. A. Blair, “Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins,” Science, vol. 292, no. 5524, pp. 2083–2086, 2001. View at Publisher · View at Google Scholar · View at Scopus
  124. M. Boaz, S. Smetana, T. Weinstein et al., “Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial,” The Lancet, vol. 356, no. 9237, pp. 1213–1218, 2000. View at Google Scholar · View at Scopus
  125. J. W. Heinecke, “Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress,” Free Radical Biology and Medicine, vol. 32, no. 11, pp. 1090–1101, 2002. View at Publisher · View at Google Scholar · View at Scopus
  126. X. Hou, J. Song, X. N. Li et al., “Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway,” Biochemical and Biophysical Research Communications, vol. 396, no. 2, pp. 199–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. C. Bellin, D. H. de Wiza, N. F. Wiernsperger, and P. Rösen, “Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin,” Hormone and Metabolic Research, vol. 38, no. 11, pp. 732–739, 2006. View at Publisher · View at Google Scholar · View at Scopus
  128. A. A. Alhaider, H. M. Korashy, M. M. Sayed-Ahmed, M. Mobark, H. Kfoury, and M. A. Mansour, “Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression,” Chemico-Biological Interactions, vol. 192, no. 3, pp. 233–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. E. Meaney, A. Vela, V. Samaniego et al., “Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 8, pp. 895–903, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. S. Yusuf, “Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients,” The New England Journal of Medicine, vol. 342, no. 3, pp. 145–153, 2000. View at Publisher · View at Google Scholar · View at Scopus
  131. C. Kovesdy, S. Bangalore, E. Imai, and E. Esquivel, “Telmisartan, Ramipril, or both in patients at high risk for vascular events. Commentary from F1000,” The New England Journal of Medicine, vol. 358, pp. 1547–1559, 2008. View at Google Scholar
  132. D. G. Harrison, H. Cai, U. Landmesser, and K. K. Griendling, “The Pickering Lecture British Hypertension Society, 10th September 2002: interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 4, no. 2, pp. 51–61, 2003. View at Google Scholar · View at Scopus
  133. K. K. Griendling, C. A. Minieri, J. D. Ollerenshaw, and R. W. Alexander, “Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells,” Circulation Research, vol. 74, no. 6, pp. 1141–1148, 1994. View at Google Scholar · View at Scopus
  134. O. H. Cingolani, N. G. Pérez, I. L. Ennis et al., “In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy,” Pflügers Archiv European Journal of Physiology, vol. 462, no. 5, pp. 733–743, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. B. V. Khan, S. Sola, W. B. Lauten et al., “Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome,” Diabetes Care, vol. 27, no. 7, pp. 1712–1715, 2004. View at Publisher · View at Google Scholar · View at Scopus
  136. J. Yoshida, K. Yamamoto, T. Mano et al., “AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure,” Hypertension, vol. 43, no. 3, pp. 686–691, 2004. View at Publisher · View at Google Scholar · View at Scopus
  137. E. J. Henriksen, “Improvement of insulin sensitivity by antagonism of the renin-angiotensin system,” American Journal of Physiology, vol. 293, no. 3, pp. R974–R980, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. E. J. Henriksen, S. Jacob, T. R. Kinnick, M. K. Teachey, and M. Krekler, “Selective angiotensin II receptor antagonism reduces insulin resistance in obese zucker rats,” Hypertension, vol. 38, no. 4, pp. 884–890, 2001. View at Google Scholar · View at Scopus
  139. C. L. Oltman, T. L. Kleinschmidt, E. P. Davidson, L. J. Coppey, D. D. Lund, and M. A. Yorek, “Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes,” Vascular Pharmacology, vol. 48, no. 1, pp. 47–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. Z. A. Al-Thanoon and I. H. Mahmood, “Effects of losartan vs. enalapril on the markers of metabolic syndrome,” Oman Medical Journal, vol. 27, no. 1, pp. 27–30, 2012. View at Publisher · View at Google Scholar · View at Scopus
  141. A. Csibi, D. Communi, N. Müller, and S. P. Bottari, “Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms,” PLoS ONE, vol. 5, no. 4, Article ID e10070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  142. Y. Wei, J. R. Sowers, R. Nistala et al., “Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells,” The Journal of Biological Chemistry, vol. 281, no. 46, pp. 35137–35146, 2006. View at Publisher · View at Google Scholar · View at Scopus